Aml world awareness day

Wei Zhang: World AML Awareness Day takes on a special meaning this year



Wei Zhang
, Professor at the Comprehensive Cancer Center of Wake Forest Baptist Medical Center, shared on LinkedIn:

“Today, April 21, is the
World AML Awareness Day
. It takes on a special meaning this year as the emotions are still very raw since the passing a week ago from AML of the one and only
Ilya Shmulevich
, who has impacted the lives of so many.

His courage and approach to life since diagnosis are just beautiful as he had always shown. In recent years, Ilya became active in AML research and was actually just awarded a new R01 on AML last year. Ilya had not only given his talents to the study of AML but also his blood and marrow for the research and for experimental therapy. He knew what he was doing might not benefit himself but he had a bigger purpose in changing the AML world for the better.

Ilya’s AML diagnosis also rekindled my interest in AML research, which was where I started my cancer research career decades ago in
Albert Deisseroth’s laboratory
. I am also excited to join my Wake Forest colleague
Tim Pardee
in a new project on AML funded by an
R21 grant
.

On this AML Aware

Five facts about AML you might not know




There are over 100 variants of blood cancer, including types of Leukaemia, Lymphoma and Myeloma. They can come in different forms from acute (fast-growing) to chronic (slow-growing).

Sunday 21
st
April marks Acute Myeloid Leukaemia (AML) World Awareness Day which sees people from across the globe unite to help raise awareness of this form of blood cancer.

We’re sharing facts about AML to educate people and help them to recognise the common signs and symptoms to look out for.



AML is a type of Leukaemia that affects the white blood cells
that originate in the bone marrow.


This form of cancer produces too many immature white blood cells which stop the body from producing the other types of cells which are essential for the immune system.



AML is one of the most common types of Leukaemia.



Other forms include Chronic Myeloid Leukaemia (CML), Acute Lymphoblastic Leukaemia (ALL), and Chronic Lymphocytic Leukaemia (CLL).



Symptoms include fatigue, bleeding, and recurring infections.



AML is the most common form of Acute Leukaemia in adults over 60.



However, it can affect people of all ages, but is known to be rare in chil

World Acute Myeloid Leukemia Day: Advancing research to serve patients



Acute myeloid leukemia (AML) is a rare and aggressive cancer of the blood and bone marrow. On April 21, World AML Day, the focus is on innovation and our commitment to the fight against hematologic cancers.




Understanding acute myeloid leukemia



Acute myeloid leukemia (AML) is a rare disease that mainly affects the elderly. It is a cancer of the blood and bone marrow that progresses rapidly in the absence of therapeutic management.


10%

The five-year survival rate for +60-year-old patients with AML is less than 10%
1



This cancer is a proliferation of immature cells, i.e., cells that are not sufficiently developed and therefore cannot function normally. These cancer cells are present in the blood, which is why we speak of “leukemia”; they come from a myeloid blast, hence the term “myeloid.”



Research & innovation, our leitmotif at Servier



Our ambition is clear: to accelerate the research and discovery of new therapeutic solutions, guided by a long-term vision.


Our teams mobilize every day to discover and develop medicines where patients’ needs are greatest.


Faced with the continual i

Know AML – Raising Awareness of This Rare Cancer


April 21 is AML World Awareness Day, a day to recognize the struggle to tackle one of the most challenging blood cancers and help raise awareness of the advances in the prevention, management, and treatment of acute myeloid leukemia (AML).


What is Acute Myeloid Leukemia (AML)? 


AML is an aggressive cancer that affects the blood and bone marrow. Though a rare type of cancer, AML is the second most common type of leukemia diagnosed in both adults and children [1]. It is characterized by the abnormal production of blood cells in the bone marrow due to genetic abnormalities. These abnormal cells, also called leukemia cells or blasts, can fill up the bone marrow and be released into the bloodstream. They then spread to other areas or organs of the body, including the brain, skin, spleen, and gums, potentially damaging or impeding their normal function.


Facing the Challenges of Treating AML


Thanks to an enormous endeavor by the research community to identify the factors that underlie the onset, progression, and relapse of AML and concurrent advances in biotechnologies, many breakthroughs have been made in developing new t